Treatment of systemic sclerosis with tocilizumab

Affiliations

• ¹ Immunomediated Systemic Diseases Unit, Medicine 4, Fernando Fonseca Hospital, Amadora and Center for Chronic Diseases (CEDOC), Faculty of Medical Sciences, New University of Lisbon, Lisbon, Portugal Immunomediated Systemic Diseases Unit, Medicine 4, Fernando Fonseca Hospital, Amadora and Center for Chronic Diseases (CEDOC), Faculty of Medical Sciences, New University of Lisbon, Lisbon, Portugal.
• ² Immunomediated Systemic Diseases Unit, Medicine 4, Fernando Fonseca Hospital, Amadora and Center for Chronic Diseases (CEDOC), Faculty of Medical Sciences, New University of Lisbon, Lisbon, Portugal.
• ³ Immunomediated Systemic Diseases Unit, Medicine 4, Fernando Fonseca Hospital, Amadora and Center for Chronic Diseases (CEDOC), Faculty of Medical Sciences, New University of Lisbon, Lisbon, Portugal Immunomediated Systemic Diseases Unit, Medicine 4, Fernando Fonseca Hospital, Amadora and Center for Chronic Diseases (CEDOC), Faculty of Medical Sciences, New University of Lisbon, Lisbon, Portugal jose.alves@fcm.unl.pt.